Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Candel Therapeutics Inc (CADL)

Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Candel Therapeutics Closes $92 Million Public Offering to Advance Cancer Immunotherapy Development Quiver Quantitative, Inc. - Tue Dec 17, 1:24AM CST

Candel Therapeutics closes public offering, raising approximately $92 million to develop cancer immunotherapy candidates.Quiver AI SummaryCandel Therapeutics, Inc. has successfully closed a public offering...

CADL : 8.75 (-12.15%)
Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares GlobeNewswire - Mon Dec 16, 3:01PM CST

CADL : 8.75 (-12.15%)
Candel Therapeutics Announces $80 Million Public Offering of Common Stock and Pre-Funded Warrants Quiver Quantitative, Inc. - Fri Dec 13, 2:12AM CST

Candel Therapeutics announces an $80 million public stock offering to fund cancer therapy development and corporate purposes.Quiver AI SummaryCandel Therapeutics, Inc. has announced an underwritten public...

CADL : 8.75 (-12.15%)
Candel Therapeutics Announces Pricing of Public Offering GlobeNewswire - Thu Dec 12, 10:00PM CST

CADL : 8.75 (-12.15%)
Candel Therapeutics Announces $80 Million Proposed Public Offering GlobeNewswire - Thu Dec 12, 3:51PM CST

CADL : 8.75 (-12.15%)
Candel Therapeutics Announces Positive Phase 3 Trial Results for CAN-2409 Viral Immunotherapy in Localized Prostate Cancer Quiver Quantitative, Inc. - Wed Dec 11, 4:18PM CST

Candel's CAN-2409 treatment shows significant disease-free survival benefits for localized prostate cancer in phase 3 trial.Quiver AI SummaryCandel Therapeutics, Inc. announced positive topline results...

CADL : 8.75 (-12.15%)
Candel Therapeutics Stock More Than Doubles After Strong Prostate Cancer Trial Results: Retail Goes Wild Stocktwits - Wed Dec 11, 11:04AM CST

Candel said it plans to initiate talks with the U.S. Food and Drug Administration (FDA) to determine the regulatory pathway for CAN-2409.

CADL : 8.75 (-12.15%)
Candel Therapeutics Announces CAN-2409 Achieved Primary Endpoint in Phase 3 Prostate Cancer Trial, Showing Significantly Improved Disease-Free Survival GlobeNewswire - Wed Dec 11, 6:00AM CST

CADL : 8.75 (-12.15%)
Candel Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights GlobeNewswire - Thu Nov 14, 7:00AM CST

CADL : 8.75 (-12.15%)
Candel Therapeutics to Present at Jefferies London Healthcare Conference 2024 GlobeNewswire - Thu Nov 7, 7:00AM CST

CADL : 8.75 (-12.15%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot